Skip to main content
Erschienen in: Supportive Care in Cancer 1/2023

Open Access 01.01.2023 | Research

Effects of esters’ cetylated fatty acids taping for chronic neck pain with mobility deficit in patients with breast cancer

verfasst von: Rosanna Izzo, Mariasole Rossato, Germano Tarantino, Nicola Mascolo, Mauro Puleio

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2023

Abstract

Purpose

To evaluate the effects of a protocol treatment based on inelastic adhesive tape with cetylated fatty acids (CFAs) esters in breast cancer survivors with chronic neck pain.

Methods

In this observational study, patients have been visited for chronic neck pain using numeric rating scale (NRS) for pain assessment, Neck Disability Index (NDI) for disability caused by neck pain, and range of movement (ROM) measures for cervical mobility. Scales have been performed at T0, after 15 days of treatment (T1) and successively after 15 days of stop treatment (T2). Patients have been treated with an inelastic adhesive tape with CFA esters (Cetilar® Tape, Pharmanutra Spa, Italy) positioned, 8 h/day for 15 days, on specific anatomic sites (upper trapezius, paravertebral cervical muscles, sub-occipitals, and/or levator scapulae muscles).

Results

Forty-five patients were included in the study. A statistically significant reduction in pain has been reported from T0 to T1 and maintained at T2 (p < 0.05); a statistically significant improvement in the mobility of the cervical spine, as evidenced by ROMs, and in disability, as resulted by Neck Disability Index, have been reported from T0 to T1 and maintained at T2; moreover, ROM at T0 correlates inversely and statistically significantly with NRS and all NDI variables at T0, similarly at T1 and T2 (p < 0.001).

Conclusions

CFA ester taping is a simple, effective, and side-effect-free treatment in order to reduce pain and improve cervical mobility in breast cancer survivors with chronic neck pain.
Hinweise

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Breast cancer is the most prevalent and incident cancer in women, with 2.3 million of new cases reported in 2020 worldwide, and 685,000 deaths during the same year [1, 2]. As reported by WHO (World Health Organization), during 2020, about 7.8 million women have survived breast cancer diagnosed in the last 5 years, thus representing the form of cancer with the highest prevalence worldwide [1]. Surgery, chemotherapy, radiotherapy, and hormonal therapy for breast cancer lead to many consequences, such as inflammation and tissue adherence, causing pain and altering the patients’ quality of life (QoL) [3, 4]. The more frequent rehabilitation problems in women with breast cancer are as follows [59]:
  • Reduction in upper limb strength and mobility
  • Upper limb lymphedema
  • Chronic pain (benign, regarding joints, and muscles)
  • Fatigue
  • Osteopenia and osteoporosis
Chronic musculoskeletal pain (CMP) is reported in 60% of breast cancer survivors: shoulder, neck, arm, and thorax are the most common sites of chronic pain, negatively affecting the quality of life [1012]. The origin of musculoskeletal pain in these patients is certainly multifactorial, as a consequence of postural post-surgery disorders, chemo and radiotherapy treatments that can worsen adhesions and consequently postural disorders, but also hormonal therapies that are associated with diffuse musculoskeletal pains (aromatase inhibitor–associated musculoskeletal syndrome (AIMSS)), and finally the psychological impact which constitutes a predisposing factor for the chronicity of pain [3, 4, 1012]. A multidisciplinary approach is proposed, including stretching, aerobic exercises, strength exercises, acupuncture, and manual therapy, not only to reduce pain and prevent chronicity, but also to improve QoL [11, 13, 14]. About CMP, neck pain with myofascial trigger points in upper trapezius muscle is widely reported in literature in breast cancer survivors [1518].
As reported by Blanpied et al. [19], neck pain can be classified into the following categories: (1) neck pain with mobility deficits, (2) neck pain with movement coordination impairments, (3) neck pain with headaches (cervicogenic headache), and (4) neck pain with radiating pain. For chronic neck pain with mobility deficits, guidelines [2022] provide a multimodal approach including thoracic and cervical manipulation, mixed exercise for cervical/scapulothoracic regions (including stretching exercises, strengthening, postural training), dry needling, laser, and intermittent mechanical/manual traction. A pharmacological approach could be proposed in case of exacerbation of pain, including topical NSAIDs, paracetamol and/or NSAIDs in initial phases, opioids, and muscle-relaxant drugs for a short period [2022].
Cetylated fatty acid (CFA) esters are acids of vegetable origin esterified with cetyl alcohol that, after topical administration, are rapidly absorbed by a passive permeation, favored by the lipid nature of the cell membranes. CFA mechanism of action includes synovial membrane protection and cell membrane stabilization, promoting normal flexibility and mobility, obtaining a reduction in pain and an increase in joint fluidity and lubrication [2329]. CFAs in topical formulations are useful in improving joint mobility, functionality, and strength, as well as reducing pain symptoms in absence of side effects in different clinical settings [3035].
The aim of our study is to evaluate the effects of a protocol treatment in chronic neck pain with mobility deficits using inelastic adhesive tape with CFA esters in breast cancer survivors.

Materials and methods

This observational quasi-experimental study has been performed at the Oncological Rehabilitation Clinic, Torre del Greco Hospital (Naples, Italy), between June and December 2021. The study has been performed in accordance with the Strengthening The Reporting Of Observational Studies In Epidemiology (Strobe) Guidelines.

Population—process

The study recruited adult women with breast cancer and suffering from neck pain who came to our clinical rehabilitation unit and were evaluated by a team of physiatrists. Women with the following characteristic: neck pain for more than 90 days, breast cancer stadium I–IIIa, surgically treated with quadrantectomy or mastectomy associated to axillary lymph node dissection and/or sentinel lymph node biopsy, and patients who have finished chemo and/or radiotherapies were included. Patients with recent neck trauma, neck surgery, NSAIDs or muscle-relaxants drugs in the last 3 weeks, active radicular pain, and active arthritis with involvement of the cervical spine were excluded from the study.

Assessment

Patients with breast cancer underwent a physical examination for chronic neck pain assessment, based on the following scales and measures:
  • Numeric rating scale (NRS) for pain assessment [36]
  • Neck disability index (NDI) for disability caused by neck pain [37, 38]
  • Range of movement (ROM) measures (flexion, extension, lateral flexion, and rotation), using a goniometry, for the mobility of the cervical spine
Scales have been performed at the first visit (T0), after 15 days of treatment (T1) and successively 15 days after the interruption of the treatment (T2). NRS requires the patients to rate their pain on a scale 0–10 where 0 is no pain and 10 is the worst pain imaginable [29]. NDI is a standard instrument for measuring self-rated disability due to neck pain; it is composed by 10 items scores from 0 to 5, its maximum score is 50, and the obtained score can be multiplied by two to produce a percentage score (minimal disability 0–20%, moderate 21–40%, severe 41–60%, disabling 61–80%, bedridden 81–100%) [30, 31]. All patients practiced cervical spine X-rays before starting the treatment, in order to confirm the benign cause of chronic neck pain.

Treatment

All patients are treated using a protocol treatment based on inelastic adhesive tape with CFA esters (Cetilar® Tape, Pharmanutra Spa, Italy) positioned, 8 h/day for 15 days, on specific anatomic sites (upper trapezius, paravertebral cervical muscles, sub-occipitals, and/or levator scapulae muscles), depending on the pain, following the model attached (see Fig. 1ac). One tape strips of about 12–14 cm in length have been used, depending on the physical conformation of the patient; tapes are for single use and not reusable.
All patients gave their written informed consent to treatment, and all authors were instructed to protect the privacy and the study procedures according to Helsinki Declaration; the study was approved by our Local Institutional review board (ASL NA3SUD Ethics Committee).

Statistical analysis

Analysis SPSS program has been used to analyze statistical data; Student t test has been used to evaluate data pre and post treatment; Pearson’s correlation has been used for data correlation; p value < 0.05 has been considered statistically significant. This observational quasi-experimental study has not been registered on Clinical Trials Registry, because it is not an intervention trial, and reflects normal clinical practice.

Results

A group of 62 patients with breast cancer and neck pain were visited in the period between June and December 2021: 11 patients had a stage disease > IIIa, so they were excluded from the study, while among the remaining 51 patients, 6 refused the treatment; therefore, 45 patients were finally included in the study (Fig. 2). In Table 1 are summarized the sample’s demographic characteristics. No adverse reactions have been reported in patients treated. The average reported age of patients was 56.2 years (range 41–64), with an average weight of 69.5 kg (range 55–89 kg); 38 patients had undergone mastectomy plus lymphadenectomy, while 7 only received quadrantectomy; 38 patients were treated with both chemotherapy and radiotherapy (Table 1).
Table 1
Sample’s demographic characteristics and clinical
Number of patients
(n = 45)
Average Age
56.2 (41–64) years
Average weight
69.5 kg
Stadium breast cancer
I 7
II 25
IIIa 13
Surgery
Quadrantectomy 7
Unilateral mastectomy 0
Mastectomy + lymphadenectomy 38
Time since surgery
 < 12 months 21
 > 12 months 24
Oncologic treatment
Chemotherapy 0
Radiotherapy 7
Both 38
Hormonal therapy 39
Menopause
Pre menopause5
Post Menopause40
Table 2 shows the average data about pain (NRS scale), disability (DNI scale), and joint mobility (ROM) at times T0, T1, and T2. A statistically significant reduction in pain on the NRS scale has been reported from T0 (6.1 ± 1.2) to T1 (2.3 ± 0.7) and maintained at T2 (2.4 ± 0.8) (p < 0.05). The pain reduction has been accompanied by a statistically significant improvement in the mobility of the cervical spine as evidenced by ROMs from T0 to T1 and maintained at T2: improvements have been reported in all directions, and more specifically in flexion (40.5 ± 3.5° at T0/53.2 ± 2.7° at T1/54.1 ± 2.2° at T2, p < 0.05), extension (42 ± 2.8° at T0/52.5 ± 1.9° at T1/53.3 ± 1.8° at T2, p < 0.05), rotation ( 40.3 ± 1.8° at T0/55.1 ± 2.4° at T1, 55.7 ± 2.3° at T2, p < 0.05), and lateral flexion (30.1 ± 1.6° at T0/45.4 ± 1.6° at T1/45.3 ± 1.8° at T2, p < 0.05). Moreover, a statistically significant improvement of the Neck Disability Index has been reported from T0 to T1 (p < 0.05), as evidenced by the reduction in moderate disability from T0 to T1 (35/45 at T0 vs 5/45 at T1) and severe disability from T0 to T1 (6/45 vs 0/45), maintained at T2, and an increase in mild disability (4/45 vs 40/45) (Fig. 3 and Table 2).
Table 2
Main results about pain (NRS scale), disability (DNI scale), and joint mobility (ROM) at T0, T1, and T2
 
T0
T1
T2
NRS
6.1 ± 1.2
2.3 ± 0.7
2.4 ± 0.8
DNI
Minimum (0–20%) N = 4
Minimum (0–20%) N = 40
Minimum (0–20%) N = 40
Moderate (21–40%) N = 35
Moderate (21–40%) N = 5
Moderate (21–40%) N = 5
Severe (41–60%) N = 6
Severe (41–60%) N = 0
Severe (41–60%) N = 0
Disabling (61–80%) N = 0
Disabling (61–80%) N = 0
Disabling (61–80%) N = 0
Bedridden (81–100%) N = 0
Bedridden (81–100%) N = 0
Bedridden (81–100%) N = 0
ROM
Flexion 40.5 ± 3.5°
Flexion 53.2 ± 2.7°
Flexion 54.1 ± 2.2°
Extension 42 ± 2.8°
Extension 52.5 ± 1.9°
Extension 53.3 ± 1.8°
Rotation 40.3 ± 1.8°
Rotation 55.1 ± 2.4°
Rotation 55.7 ± 2.3°
Lateral flexion 30.1 ± 1.6°
Lateral flexion 45.4 ± 1.6°
Lateral flexion 45.3 ± 1.8°
NRS numeric rating scale, DNI disability neck index, ROM range of movement
Table 3 shows the results obtained correlating ROM with NRS and DNI scale using Pearson test: interestingly, ROM at T0 correlates inversely and statistically significantly with NRS at T0, similarly at T1 and T2 (p < 0.001), indicating pain reduction improves cervical spine mobility; in addition, there is an inverse and statistically significant correlation between ROM and all NDI variables (p < 0.001), indicating mobility improvement is associated with disability reduction.
Table 3
Correlation results between ROM and DNI, ROM and NRS at T0, T1, and T2, using Pearson test
 
ROM
DNI
T0 T1 T2
R =  − 0.664 R =  − 0.659 R =  − 0.662
p < 0.001 p < 0.001 p < 0.001
NRS
T0 T1 T2
R =  − 0.677 R =  − 0.664 R =  − 0.664
p < 0.001 p < 0.001 p < 0.001
DNI disability neck index, NRS numeric rating scale, ROM range of movement

Discussion

Many breast cancer survivors will experience physical and psychological sequelae that affect their everyday lives. The side effects of treatment as well as inactivity secondary to treatment can impair activity and participation, decrease independence, and affect quality of life [7]. Chronic neck pain in breast cancer survivors is well reported in literature [10, 1518]: Caro-Moran et al. [17] evidenced how pressure pain threshold on trapezius and dorsal muscles are lower on the side of surgically breast treated than on the contralateral side, showing greater pain in this area. Fernandez-Lao et al. [18] reported myofascial trigger points in neck and shoulder muscles and widespread pressure pain hypersensitivity in patients with postmastectomy pain: specifically, the local and referred pain elicited by active myofascial trigger points produced neck and shoulder/axillary complaints in these patients, suggesting peripheral and central sensitization in patients with postmastectomy pain. Similarly, Dibai-Filho et al. [15] reported higher intensity of myofascial pain on upper trapezius in breast cancer survivors, compared to chronic neck pain in women without breast cancer, indicating the need for a careful assessment and treatment of this pain condition. Pharmacological approach could be proposed only for a short period and in case of exacerbation of pain. Physiotherapy, specifically manual therapy, is surely a valid option to obtain better functional results and pain control, but it requires frequent sessions with a physiotherapist to be effective [10]. To design our work, we consider the study of Sharan et al. [32] that compare a group treated with physical therapies + CFA cream and a control group treated only with physical therapies and placebo cream, obtaining better results when physiotherapy was combined with CFAs cream. Various studies report the benefits of CFA topical application on knee osteoarthritis, improving ROM, pain, gait pattern, stiffness articulation, and consequentially quality of life [3035].
In this study, a group of patients suffering from a specific cancer-related disease showed a significant pain reduction and a significant improve in mobility. The reduction in moderate disability in favor of minimal disability after 15 days (T1) is the main goal of this study, to allow women to recover in a short time and their activities of daily living and improve their quality of life. Moreover, the data of the maintenance of this result after 15 days without treatment (T2), which shows that the benefit obtained is maintained over time, is equally important.
In this specific historic period characterized by the Sars-CoV2 pandemic, access to rehabilitation and physiotherapy treatment (both in- and outpatient) has often been difficult for patients [39]; in fact, some studies in literature have suggested telerehabilitation in breast cancer survivors too [40]. Considering these difficulties, a topic treatment simple and easy to use, self-applicable at home, without side effects, has been well accepted by patients, reporting good results on their pain and neck pain-related disability.
Our study certainly has some limitations: the absence of a control group, the short follow-up, the lack of association with a physiotherapy treatment. Further studies could be needed to confirm how long the treatment is effective, to evaluate if and when the pain recurs and its intensity, and how to repeat the treatment (for a shorter or the same period of 15 days).
In conclusion, a protocol treatment based on inelastic adhesive tape with cetylated fatty acid (CFA) esters showed to be simple, effective, and easily manageable, especially when it is difficult access to rehabilitation treatment, as what happened during the pandemic in order to reduce pain and improve cervical mobility in breast cancer survivors with chronic neck pain. According to our results, this therapeutic strategy could be helpful in these patients, and also in patients with the same condition, for improvement in pain, mobility, and disability in activities of daily living.

Declarations

Ethical approval

This is an observational quasi-experimental study. The ASL NA3SUD Ethics Committee has confirmed that no ethical approval is required.
Informed consent was obtained from all individual participants included in the study.

Competing interests

The authors declare no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Literatur
1.
2.
5.
Zurück zum Zitat Harris SR, Schmitz KH, Campbell KL, McNeely ML (2012) Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer 118(Suppl):2312–2324CrossRef Harris SR, Schmitz KH, Campbell KL, McNeely ML (2012) Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer 118(Suppl):2312–2324CrossRef
6.
Zurück zum Zitat DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515CrossRef DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515CrossRef
7.
Zurück zum Zitat Brach M, Cieza A, Stucki G, Füssl M, Cole A, Ellerin B, Fialka-Moser V, Kostanjsek N, Melvin J (2004) ICF core sets for breast cancer. J Rehabil Med 44(Suppl):121–127CrossRef Brach M, Cieza A, Stucki G, Füssl M, Cole A, Ellerin B, Fialka-Moser V, Kostanjsek N, Melvin J (2004) ICF core sets for breast cancer. J Rehabil Med 44(Suppl):121–127CrossRef
8.
Zurück zum Zitat Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D, Society for Integrative Oncology (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014:346–58CrossRef Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D, Society for Integrative Oncology (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014:346–58CrossRef
9.
Zurück zum Zitat Izzo R, Scibilia G, Pinto M, Bernetti A, Ceravolo MG, Paolucci T (2018). Buone pratiche e line guida riabilitative nel trattamento delle neoplasie. In: Linee Guida, Buone Pratiche ed Evidenze Scientifiche in Medicina Fisica e Riabilitativa, II Volume, pp 793–870 Izzo R, Scibilia G, Pinto M, Bernetti A, Ceravolo MG, Paolucci T (2018). Buone pratiche e line guida riabilitative nel trattamento delle neoplasie. In: Linee Guida, Buone Pratiche ed Evidenze Scientifiche in Medicina Fisica e Riabilitativa, II Volume, pp 793–870
10.
Zurück zum Zitat Hidalgo B, Hall T, Bossert J, Dugeny A, Cagnie B, Pitance L (2017) The efficacy of manual therapy and exercise for treating non-specific neck pain: a systematic review. J Back Musculoskelet Rehabil 30:1149–1169CrossRef Hidalgo B, Hall T, Bossert J, Dugeny A, Cagnie B, Pitance L (2017) The efficacy of manual therapy and exercise for treating non-specific neck pain: a systematic review. J Back Musculoskelet Rehabil 30:1149–1169CrossRef
13.
Zurück zum Zitat Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 20(34):611–635. https://doi.org/10.1200/JCO.2015.64.3809CrossRef Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 20(34):611–635. https://​doi.​org/​10.​1200/​JCO.​2015.​64.​3809CrossRef
14.
Zurück zum Zitat De Groef A, Van Kampen M, Dieltjens E, Christiaens MR, Neven P, Geraerts I, Devoogdt N (2015) Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil 96:1140–1153CrossRef De Groef A, Van Kampen M, Dieltjens E, Christiaens MR, Neven P, Geraerts I, Devoogdt N (2015) Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil 96:1140–1153CrossRef
15.
Zurück zum Zitat Dibai-Filho AV, de Jesus Guirro RR, Koga Ferreira VT, Kelly de Oliveira A, Maria de Almeida A, de Oliveira Guirro EC (2018) Analysis of chronic myofascial pain in the upper trapezius muscle of breast cancer survivors and women with neck pain. J Bodyw Mov Ther 22:237–241CrossRef Dibai-Filho AV, de Jesus Guirro RR, Koga Ferreira VT, Kelly de Oliveira A, Maria de Almeida A, de Oliveira Guirro EC (2018) Analysis of chronic myofascial pain in the upper trapezius muscle of breast cancer survivors and women with neck pain. J Bodyw Mov Ther 22:237–241CrossRef
16.
Zurück zum Zitat Castro-Martin E, Ortiz-Comino L, Gallart-Aragon T, Esteban-Moreno B, Arroyo-Morales M, Galiano-Castillo N (2018) Myofascial induction effects on neck-shoulder pain in breast cancer survivors: randomized, single-blind, placebo-controlled crossover design. Arch Phys Med Rehabil 98:832–840CrossRef Castro-Martin E, Ortiz-Comino L, Gallart-Aragon T, Esteban-Moreno B, Arroyo-Morales M, Galiano-Castillo N (2018) Myofascial induction effects on neck-shoulder pain in breast cancer survivors: randomized, single-blind, placebo-controlled crossover design. Arch Phys Med Rehabil 98:832–840CrossRef
17.
Zurück zum Zitat Caro-Moran E, Fernandez-Lao C, Diaz-Rodriguez L, Cantarero-Villanueva I, Madeleine P, Arroyo-Morales M (2016) Pressure pain sensitivity maps of the neck-shoulder region in breast cancer survivors. Pain Med 17:1942–1952CrossRef Caro-Moran E, Fernandez-Lao C, Diaz-Rodriguez L, Cantarero-Villanueva I, Madeleine P, Arroyo-Morales M (2016) Pressure pain sensitivity maps of the neck-shoulder region in breast cancer survivors. Pain Med 17:1942–1952CrossRef
18.
Zurück zum Zitat Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-Las-Peñas C, Del-Moral-Ávila R, Arendt-Nielsen L, Arroyo-Morales M (2010) Myofascial trigger points in neck and shoulder muscles and widespread pressure pain hypersensitivtiy in patients with postmastectomy pain: evidence of peripheral and central sensitization. Clin J Pain 26(9):798–806. https://doi.org/10.1097/AJP.0b013e3181f18c36CrossRef Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-Las-Peñas C, Del-Moral-Ávila R, Arendt-Nielsen L, Arroyo-Morales M (2010) Myofascial trigger points in neck and shoulder muscles and widespread pressure pain hypersensitivtiy in patients with postmastectomy pain: evidence of peripheral and central sensitization. Clin J Pain 26(9):798–806. https://​doi.​org/​10.​1097/​AJP.​0b013e3181f18c36​CrossRef
20.
21.
Zurück zum Zitat Cote P, Wong JJ, Sutton D, Shearer HM, Mior S, Randhawa K et al (2016) Management of neck pain and associated disorders: a clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur Spine J 25:2000–2022CrossRef Cote P, Wong JJ, Sutton D, Shearer HM, Mior S, Randhawa K et al (2016) Management of neck pain and associated disorders: a clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur Spine J 25:2000–2022CrossRef
22.
Zurück zum Zitat Kjaer P, Kongsted A, Hartvigsen J, Isenberg-Jorgensen A, Schiottz-Christenseb B, Soborg B, Krog C et al (2017) National clinicl guidelines for non-surgical treatment of patients with recent onset neck pain or cervical radiculopathy. Eur Spine J 26:2242–2257CrossRef Kjaer P, Kongsted A, Hartvigsen J, Isenberg-Jorgensen A, Schiottz-Christenseb B, Soborg B, Krog C et al (2017) National clinicl guidelines for non-surgical treatment of patients with recent onset neck pain or cervical radiculopathy. Eur Spine J 26:2242–2257CrossRef
23.
Zurück zum Zitat Diehl HW, May EL (1994) Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats. J Pharm Sci 83:296–299CrossRef Diehl HW, May EL (1994) Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats. J Pharm Sci 83:296–299CrossRef
25.
Zurück zum Zitat Hesslink R Jr, Armstrong D, Nagendran MV, Sreevastan S, Barathur R (2002) Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatol 29:1708–12 Hesslink R Jr, Armstrong D, Nagendran MV, Sreevastan S, Barathur R (2002) Cetylated fatty acids improve knee function in patients with osteoarthritis. J Rheumatol 29:1708–12
26.
Zurück zum Zitat De Caterina R, Liao JK, Libby P (2000) Fatty acid modulation of endothelial activation. Am J Clin Nutr 71:213S-S223CrossRef De Caterina R, Liao JK, Libby P (2000) Fatty acid modulation of endothelial activation. Am J Clin Nutr 71:213S-S223CrossRef
27.
Zurück zum Zitat James MJ, Gibson RA, Cleland LG (2000) Dietary polyunsaturated mediator production. Am J Clinc Nutr 71:343S-S348CrossRef James MJ, Gibson RA, Cleland LG (2000) Dietary polyunsaturated mediator production. Am J Clinc Nutr 71:343S-S348CrossRef
28.
Zurück zum Zitat Kremer JM (2000) N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 71:349S-S351CrossRef Kremer JM (2000) N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 71:349S-S351CrossRef
29.
Zurück zum Zitat Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B (2000) N-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 275:721–724CrossRef Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B (2000) N-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 275:721–724CrossRef
30.
Zurück zum Zitat Kraemer WJ, Ratamess NA, Maresh CM, Anderson JA, Volek JS, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gómez AL, Silvestre R, Hesslink RL Jr (2005) A cetylated fatty acid topical cream with menthol reduces pain and improves functional performance in individuals with arthritis. J Strength Cond Res 19:475–480. https://doi.org/10.1519/R-505059.1CrossRef Kraemer WJ, Ratamess NA, Maresh CM, Anderson JA, Volek JS, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gómez AL, Silvestre R, Hesslink RL Jr (2005) A cetylated fatty acid topical cream with menthol reduces pain and improves functional performance in individuals with arthritis. J Strength Cond Res 19:475–480. https://​doi.​org/​10.​1519/​R-505059.​1CrossRef
31.
Zurück zum Zitat Kraemer WJ, Ratamess NA, Maresh CM, Anderson JA, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gómez AL, Volek JS, Silvestre R, Hesslink RL Jr (2005) Effects of treatment with a cetylated fatty acid topical cream on static postural stability and plantar pressure distribution in patients with knee osteoarthritis. J Strength Cond Res 19:115–121 Kraemer WJ, Ratamess NA, Maresh CM, Anderson JA, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gómez AL, Volek JS, Silvestre R, Hesslink RL Jr (2005) Effects of treatment with a cetylated fatty acid topical cream on static postural stability and plantar pressure distribution in patients with knee osteoarthritis. J Strength Cond Res 19:115–121
32.
Zurück zum Zitat Sharan D, Jacob BN, Ajeesh PS, Bookout JB, Barathur RR (2011) The effect of cetylated fatty esters and physical therapy on myofascial pain syndrome of the neck. J Bodyw Mov Ther 15:363–374CrossRef Sharan D, Jacob BN, Ajeesh PS, Bookout JB, Barathur RR (2011) The effect of cetylated fatty esters and physical therapy on myofascial pain syndrome of the neck. J Bodyw Mov Ther 15:363–374CrossRef
33.
Zurück zum Zitat Kraemer WJ, Ratamess NA, Anderson JM, Maresh CM, Tiberio DP, Joyce ME, Messinger BN, French DN, Rubin MR, Gómez AL, Volek JS, Hesslink R Jr (2004) Effect of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis. J Rheumatol 31:767–774 Kraemer WJ, Ratamess NA, Anderson JM, Maresh CM, Tiberio DP, Joyce ME, Messinger BN, French DN, Rubin MR, Gómez AL, Volek JS, Hesslink R Jr (2004) Effect of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis. J Rheumatol 31:767–774
34.
Zurück zum Zitat Ariani A, Parisi S, Guidelli GM, Bardelli M, Bertini A, Fusaro E (2018) Short-term effect of topical cetylated fatty acid on early and advanced knee osteoarthritis: a multi-center study. Arch Rheumatol 23(33):438–442CrossRef Ariani A, Parisi S, Guidelli GM, Bardelli M, Bertini A, Fusaro E (2018) Short-term effect of topical cetylated fatty acid on early and advanced knee osteoarthritis: a multi-center study. Arch Rheumatol 23(33):438–442CrossRef
35.
Zurück zum Zitat Pampaloni E, Pera E, Maggi D, Lucchinelli R, Chiappino D, Costa A, Venturini V, Tarantino G (2020) Association of cetylated fatty acid treatment with physical therapy improves athletic pubalgia symptoms in professional roller hockey players. Heliyon 6:e04526CrossRef Pampaloni E, Pera E, Maggi D, Lucchinelli R, Chiappino D, Costa A, Venturini V, Tarantino G (2020) Association of cetylated fatty acid treatment with physical therapy improves athletic pubalgia symptoms in professional roller hockey players. Heliyon 6:e04526CrossRef
36.
Zurück zum Zitat Lazaridou A, Elbaridi N, Edwards RR, Berde CB (2018) Chapter 5 - Pain Assessment. In: Benzon HT, Raja SN, Liu SS, Fishman SM, Cohen SP (eds) Essentials of pain medicine, 4th edn. Elsevier, pp 39-46.e1CrossRef Lazaridou A, Elbaridi N, Edwards RR, Berde CB (2018) Chapter 5 - Pain Assessment. In: Benzon HT, Raja SN, Liu SS, Fishman SM, Cohen SP (eds) Essentials of pain medicine, 4th edn. Elsevier, pp 39-46.e1CrossRef
37.
Zurück zum Zitat Vernon H (2008) The Neck Disability Index: state-of-the-art, 1991–2008. J Manipulative Physiol Ther 31:491–502CrossRef Vernon H (2008) The Neck Disability Index: state-of-the-art, 1991–2008. J Manipulative Physiol Ther 31:491–502CrossRef
38.
Zurück zum Zitat Young IA, Dunning J, Butts R, Mourad F, Cleland JA (2019) Reliability, construct validity, and responsiveness of the neck disability index and numeric pain rating scale in patients with mechanical neck pain without upper extremity symptoms. Physiother Theory Pract 35:1328–1335CrossRef Young IA, Dunning J, Butts R, Mourad F, Cleland JA (2019) Reliability, construct validity, and responsiveness of the neck disability index and numeric pain rating scale in patients with mechanical neck pain without upper extremity symptoms. Physiother Theory Pract 35:1328–1335CrossRef
40.
Zurück zum Zitat De Rezence LF, Francisco VE, Franco RL (2021) Telerehabilitation for patients with breast cancer through the COVID-19 pandemic. Breast Cancer Res Treat 185:257–259CrossRef De Rezence LF, Francisco VE, Franco RL (2021) Telerehabilitation for patients with breast cancer through the COVID-19 pandemic. Breast Cancer Res Treat 185:257–259CrossRef
Metadaten
Titel
Effects of esters’ cetylated fatty acids taping for chronic neck pain with mobility deficit in patients with breast cancer
verfasst von
Rosanna Izzo
Mariasole Rossato
Germano Tarantino
Nicola Mascolo
Mauro Puleio
Publikationsdatum
01.01.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-022-07497-2

Weitere Artikel der Ausgabe 1/2023

Supportive Care in Cancer 1/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.